AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Clodronate reduces risk of bone metastases in breast ca patients. (Bisphosphonate not on U.S. Market).

Internal Medicine News

| November 15, 2002 | Zoler, Mitchel L. | COPYRIGHT 2002 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

SAN ANTONIO -- Treatment with clodronate cut the incidence of bone metastases in women with breast cancer in a controlled study with more than 71,000 patients.

Women treated with clodronate, a bisphosphonate that's not yet available in this country, also had their rate of all-cause mortality cut by 23% during a median follow-up period of 5.5 years, Dr. Eugene V. McCloskey reported in a poster at the annual meeting of the American Society for Bone and Mineral Research.

The difference in mortality between the clodronate-treated and control groups fell just short of being statistically significant.

Clodronate is not approved for use in the United States, but is in the same class of drugs as approved agents such as alendronate and risedronate. The Finnish company that makes clodronate, Leiras, is considering seeking Food and Drug Administration approval for the drug, said Dr. McCloskey, a senior clinical research fellow in the metabolic unit of the University of Sheffield (England). Leiras funded the study that he reported.

The study included women with ...

Related articles from newspapers, magazines, journals, and more
New Study Shows Reduction in Bone Metastases for Patients Taking Oral...
Press release article from: PR Newswire Europe March 27, 2006 700+ words
...and Incidence of Bone Metastases According to recent...protection against bone metastases. The results, presented...demonstrated that women treated with oral Bonefos...chances of developing bone metastases within the first...
Bone metastases: can you teach an old drug new tricks?
Press release article from: M2 Presswire May 13, 2008 700+ words
...PRESSWIRE-13 May 2008-DATAMONITOR: Bone metastases: can you teach an old drug new tricks...the bone. Patients affected with bone metastases require supportive therapy in addition...bisphosphonates currently used to treat bone metastases reduce the risk of skeletal complications...
Bone metastases - can you teach an old drug new tricks? asks Datamonitor.
Newspaper article from: Pharma Marketletter May 26, 2008 700+ words
...the bone. Patients affected with bone metastases require supportive therapy in addition...bisphosphonates currently used to treat bone metastases reduce the risk of skeletal complications...bisphosphonates may effectively prevent bone metastases in early-stage cancer patients...
Stakeholder Opinions: Bone Metastases Presents Current Treatment Options And...
Press release article from: M2 Presswire April 25, 2008 700+ words
...Markets: Stakeholder Opinions: Bone Metastases Presents Current Treatment...Identification Of Unmet Needs In Bone Metastases(C)1994-2008 M2 COMMUNICATIONS...of "Stakeholder Opinions: Bone Metastases - Impending Patent Expiries...
Stakeholder Opinions: Bone Metastases Presents Current Treatment Options and...
Press release article from: Business Wire April 25, 2008 700+ words
...addition of "Stakeholder Opinions: Bone Metastases - Impending Patent Expiries May Help...Newer Agents" to their offering. Bone metastases are a complication of some advanced...kidney and thyroid. The incidence of bone metastases across these tumour types in the seven...
Research and Markets: Bisphosphonates Update - The Treatment and Prevention of...
Press release article from: Business Wire September 22, 2004 700+ words
...Ireland -- New Treatment Imminent For Bone Metastases In Breast And Prostate Cancer Research...The Treatment and Prevention of Bone Metastases in Breast and Prostate Cancer to their...This Brief examines trends in the bone metastases market for both prostate and breast...
New Analysis Demonstrates Additional Benefits of Clodronate as an Adjuvant...
Press release article from: PR Newswire December 9, 2004 700+ words
...clodronate reduced the occurrence of bone metastases and increased survival in this patient...patients who eventually developed bone metastases. "Several studies have already confirmed...benefits of clodronate in reducing bone metastases and increasing survival in women with...
History of HRT use tied to fewer bone metastases. (Breast Cancer Patients).
Magazine article from: OB GYN News Jancin, Bruce March 15, 2003 700+ words
...significantly reduced incidence of bone metastases, Dr. Ingo J. Diel said at a breast...the lowest incidence of death and bone metastases. (See table.) Particularly noteworthy...postmenopausal/ no-HRT group had primary bone metastases at the time of breast surgery, compared...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA